本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Nurix Therapeutics

26.27
-0.4500-1.68%
盤後26.310.0400+0.15%19:30 EDT
成交量:87.42萬
成交額:2,301.87萬
市值:27.16億
市盈率:-7.70
高:26.69
開:26.37
低:25.86
收:26.72
52周最高:28.23
52周最低:8.20
股本:1.03億
流通股本:9,504.52萬
量比:0.66
換手率:0.92%
股息:- -
股息率:- -
每股收益(TTM):-3.4102
每股收益(LYR):-3.0514
淨資產收益率:-80.30%
總資產收益率:-40.06%
市淨率:6.75
市盈率(LYR):-8.61

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report